Many Bright Ideas Technologies Inc. does not have significant operations. Previously, the company was involved in the life science business with a focus on the commercialization of prognostic genomic-based tests for non-small-cell lung cancer. It also focuses on the commercialization of technologies in various industrial sectors. The company is headquartered in Vancouver, Canada.
Research context
Med BioGene Inc appears in PyInvesting’s TSX Venture Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Diagnostics & Research
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Med BioGene Inc is currently in a long term uptrend where the price is trading 95.5% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Med BioGene Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has dropped by 177.0% to $-9K since the same quarter in the previous year.
Finally, its free cash flow grew by 779.3% to $83K since the same quarter in the previous year.
Based on the above factors, Med BioGene Inc gets an overall score of 3/5.